51 – 60 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
- Contribution to journal › Article
-
Mark
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
- Contribution to journal › Scientific review
- 2018
-
Mark
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
- Contribution to journal › Article
-
Mark
Hospitalizations due to systemic connective tissue diseases: : Secular trends and regional disparities in Sweden, 1998-2016
- Contribution to journal › Article
-
Mark
Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature
- Contribution to journal › Letter
-
Mark
Brief Report : Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
- Contribution to journal › Article
-
Mark
Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden
(2018) American College of Rheumatology (ACR) Annual Meeting In Arthritis & Rheumatology 70(Suppl 9).
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
- Contribution to journal › Article
-
Mark
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis : The influence of ANCA subtype
- Contribution to journal › Article
- 2016
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
- Contribution to journal › Article
